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3919-Symp
Single Molecules in Single Cells: A System-Wide Quantification of Gene
Expression
Sunney Xie.
Harvard University, Cambridge, MA, USA.
Our group studied gene expression in living bacterial cells with single-molecule
sensitivity with millisecond time resolution and nm spatial precision. We re-
ported the first movie of protein production, one molecule at a time, binding
and unbinding kinetics of transcription factors on DNA, and their single-mole-
cule events that change the cell’s phenotype. We recently conducted system-
wide studies of transcriptome and proteome with single-molecule sensitivity in
a single cell. We are investigating the phenomenon of persisters, abnormal and
rare bacterial cells that have the same genes as normal cells, but are phenotypi-
cally drug tolerant, hoping to provide clues for developing tuberculosis drugs.
3920-Symp
Probing Intracellular Kinetics at the Level of Single Molecules
Johan Elf.
Uppsala University, Uppsala, Sweden.
I will present our resent advancements in tracking individual freely diffusing
fluorescent proteins molecules at high time resolution in the cytoplasm of bac-
terial cells. In vivo tracking of individual proteins molecules makes it possible
to study kinetics high time resolution without synchronizing the population of
molecules. For example by monitoring the kinetics of the response mediator
RelA we have developed a single molecule assay to study stress response
and starvation at the level of individual bacteria.
The RelA protein binds to a small fraction of ribosomes, where it synthesizes
the global transcriptional regulator ppGpp in response to amino acids depriva-
tion. This the ppGpp molecule binds to the RNAP and rapidly reprograms the
cell for the new environment, in what is called the stringent response. While
E. coli contains on average about 100 RelA molecules, using a photo-activat-
able fluorescent probe we can activate only a few fluorescent molecules per
cell at any given time and track them at high time resolution. The procedure
can be repeated many times to get accurate statistics for in individual cells.
When the cell grows exponentially, RelA trajectories closely resemble trajec-
tories of fluorescently tagged ribosomal proteins (D~0.4umt2/sec as
compared to D~0.3 umt2/sec for ribosomes). After nutritional downshift,
RelA binding kinetics changes rapidly and the protein diffuses very fast
(D~3.5umt2/sec) as if it only binds to ribosomes transiently. The assay has
made it possible to study the rapid and transient stringent response in individual
cell as well as the heterogeneity in the stress response over the population.
3921-Symp
Error Minization in Lateral Inhibition Circuits
Naama Barkai.
Weizmann Inst, Rehovot, Israel.
No Abstract.
3922-Symp
Signaling Dynamics at the Single Cell Level
Michael Elowitz.
California Inst Tech, Pasadena, CA, USA.
Our lab studies the dynamics of gene circuits at the single-cell level. This talk
will focus on signal encoding schemes used in different prokaryotic and
eukaryotic signal transduction systems. In particular, I will discuss new,
dynamic encoding schemes and their possible functions.Symposium 21: Mechanism of Electromechanical
Coupling in Voltage-gated Ion Channels
3923-Symp
The Structural Basis of Voltage Sensing
Roderick MacKinnon.
Rockefeller Univ, HHMI, New York, NY, USA.
No Abstract.
3924-Symp
The Structural Basis of Gating Currents: Insights from Fluorescence
Spectroscopy
Francisco Bezanilla.
Univ Chicago, Chicago, IL, USA.The S4-based voltage sensor found in voltage-gated ion channels and in voltage
dependent phosphatases plays a fundamental role in controlling cellular excit-
ability. Although recently the combination of electrophysiology, mutagenesis,
spectroscopy and X-ray crystallography have delineated the basic molecular
correlates of the voltage sensor operation, we still are far from understanding
the physical basis of the sensing (gating) currents. The study of sensing currents
show that the sensor visits three main states: Resting, Active and Relaxed
(inactivated). Furthermore, between the Resting and Activestatesthere is at
least another major state that can be modulated by mutations. In addition, we
know with a fair degree of precision, the kinetics and magnitude of the charge
moving among the different states. However, the structural correlates of these
states and transitions are for the most part unknown. Fluorescence spectroscopy
, concomitant with electrophysiology, has been used to detect conformational
changes. Thus, local changes within the sensor are detected by following mod-
ifications in the environment of a fluorophore probe situated in specified sites
and changes in conformations have been detected and quantified as intramolec-
ular distance changes using the LRET technique. These techniques are espe-
cially critical in characterizing the short-lived Active state that is populated
by positive potentials and spontaneously decays to the Relaxed state within
tens to hundreds of milliseconds. As the Relaxed state is stable, it is most likely
the state that X-ray crystallography has caught. Fluorescence spectroscopy con-
firmed that indeed there are three main states and that they each correspond to
different conformations of the voltage sensor. In addition, it has provided the
kinetics of the conformational changes and estimates of the relative movements
of the voltage sensor while evolving from Resting to Active to Relaxed. Sup-
port: NIHGM030376.
3925-Symp
Dynamics of Voltage-Sensor Movement in Sodium Channels
Todd Scheuer.
Univ Washington, Seattle, WA, USA.
Voltage-gating of ion channels is driven by the S4 segment residing in a gating
pore in proximity to S1, S2 and S3 segments of the voltage sensing module of
the channels. Molecular modeling using Rosetta has proposed detailed move-
ments of the S4 voltage sensor in the gating pore during gating. As it transits
between deactivated and activated conformations, voltage sensor arginines
are hypothesized to make sequential ion pairs with negatively-charged residues
in surrounding transmembrane segments that catalyze the transmembrane
movement of the voltage-sensor positive charges; the charge-charge pairs
also prevent movement of solution ions through the gating pore. We have
used two approaches to test this model. First, using mammalian sodium chan-
nels we have shown that substitutions of glutamine for the two most extracel-
lular arginines allows current through the gating pore at hyperpolarized poten-
tials where predicted charge-charge interactions are missing due to mutation,
but not at depolarized potentials where the remaining more intracellular and
unmutated arginines are predicted to form pairs and block the gating pore. Con-
versely, glutamine substitutions for arginines 2 and 3 allows gating pore current
at depolarized but not hyperpolarized potentials. In a second approach, we have
used bacterial NaChBac sodium channels and substituted pairs of cysteines for
negatively-charged amino acids in S2 and positively-charged arginines in S4
that are predicted to interact during gating. We demonstrate rapid disulfide
bond formation between the substituted cysteines that is voltage (and confor-
mation) dependent. The time and voltage-dependence of these disulfide inter-
actions provide experimental evidence for sequential formation of specific
ion pairs as the voltage sensor moves within the gating pore during channel ac-
tivation. The combination of these experimental approaches gives an increas-
ingly detailed picture of the conformations and interactions of S4 in the gating
pore during voltage-sensor activation.
3926-Symp
Molecular Movements within the Voltage-Sensor Domain of a Potassium
Channel
Fredrik Elinder.
Linko¨ping Univ, Linko¨ping, Sweden.
Voltage-gated ion channels play critical roles in all biological systems, for
instance in transmitting the nervous impulse and initiating the heart beat.
Changes in the membrane potential are detected by a voltage sensor in the
channel, leading to opening and closing of the ion-conducting pore. While
the atomic structure is known of a voltage-gated K channel in an activated state,
the chain of molecular events leading to channel gating is known in less detail.
We have used disulfide-linking techniques in combination with electrophysiol-
ogy to probe molecular motion within the channel protein. Two amino-acid res-
idues are mutated to cysteins and if these residues are close enough to each
other it is possible to make and break disulfide or cadmium bridges, detected
as a change in channel function. The analysis also gives information about if
Wednesday, February 24, 2010 755athe residues are close to each other in closed, open or inactivated states. With
this technique, we have detected and analyzed molecular movements within the
voltage-sensor domain, between the voltage sensor and the pore domain, and
within the pore domain.Minisymposium 4: New Chemical Modulators by
Rational Design
3927-MiniSymp
Optimizing Ligand-Protein Interactions Via Silcs: Site Identification by
Ligand Competitive Saturation
Alexander MacKerell.
Univ Maryland, Baltimore, MD, USA.
Fragment-based methods for drug optimization have great potential; however,
time, expense and sensitivity considerations associated with NMR and x-ray
crystallographic based methods limit their applicability. As an alternative we
have developed a computational approach, SILCS: Site Identification by
Ligand Competitive Saturation, that uses explicit solvent all-atom molecular
dynamics to identify binding sites on protein surfaces for functional groups.
Information from the SILCS approach may then be combined with structural
information on an inhibitor-protein complex to facilitate modification of the
ligand to improve its binding affinity. An overview of SILCS and its application
to inhibitor-ligand optimization will be presented.
3928-MiniSymp
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific
Drug Binding
Stephen G. Aller.
Univ. Alabama at Birmingham, Birmingham, AL, USA.
P-glycoprotein (Pgp) detoxifies cells by exporting hundreds of chemically unre-
lated toxins but causesmultidrug resistance in the treatment of cancers. Substrate
promiscuity is a hallmarkof Pgp activity, thus a structural descriptionof polyspe-
cific drug-binding is vital for the rational design of anticancer drugs and MDR
inhibitors. The x-ray structure of apo-Pgp at 3.8 A˚ reveals an internal cavity of
~6,000 A˚3 with a 30 A˚ separation of the two nucleotide binding domains
(NBD). Two additional Pgp structures with novel cyclic peptide inhibitors dem-
onstrate distinct drug binding sites in the internal cavity capable of stereo-selec-
tivity that is based on hydrophobic and aromatic interactions. Apo- and drug-
bound Pgp structures have portals open to the cytoplasm and the inner leaflet
of the lipid bilayer for drug entry. The inward-facing conformation represents
an initial stage of the transport cycle that is competent for drug binding.
3929-MiniSymp
Chemical Synthesis of a Highly Selective Probe of the Renal Outer
Medullary Potassium Channel (ROMK)
Jerod S. Denton, Brian A. Chauder, Rishin Kadakia, Eric S. Dawson,
Craig W. Lindsley, C. David Weaver, Gautam Bhave.
Vanderbilt University School of Medicine, Nashville, TN, USA.
The renal outer medullary potassium channel, ROMK, critically regulates salt
and water balance and may be a drug target for a novel class of diuretic. How-
ever, the molecular pharmacology of the inward rectifier potassium channel
family is virtually undeveloped, precluding assessment of ROMK’s therapeutic
potential. We therefore performed a high-throughput screen of approximately
225,000 small molecules for modulators of ROMK function, from which sev-
eral novel antagonists were identified. One compound, termed VU590, inhibits
ROMK with a half-inhibition concentration (IC50) of 300 nM, has no effect on
Kir2.1 or Kir4.1, but inhibits Kir7.1 at low micromolar concentrations. Two
structurally related compounds were identified in the screen, but were found
to be comparatively weak ROMK inhibitors. Using a molecular mechanics-
based knowledge of VU590, medicinal chemistry was employed to improve
the potency of one compound 33-fold (IC50 from 8 mM to 240 nM). This novel
probe, termed VU591, is highly selective for ROMK over Kir2.1, Kir2.3,
Kir4.1, Kir6.2/SUR1B, Kir7.1 and a panel of more than 65 other potential
off-targets, including voltage-gated sodium and calcium channels and hERG.
Functional studies suggest the VU591 binding site is located in the cytoplasmic
pore of ROMK. VU591 will be instrumental in mapping the location and topo-
graphical features of this selective binding site and could pave the way for an-
imal studies assessing the therapeutic potential of ROMK.
3930-MiniSymp
Gold Nanoparticles as a Platform for Designing Protein-Protein Interac-
tion Inhibitors: Application to Ubiquitin-Like Modifications
Yang Su, Angela Perkins, Yi-Jia Li, Yuelong Ma, David Horne, Yuan Chen.
Beckman Research Institute of the City of Hope, Duarte, CA, USA.Inhibitors of non-covalent protein-protein interactions hold much promise as
useful probes to our understanding of human biology and disease mechanisms,
as well as leads for developing new therapies. Developing such inhibitors, how-
ever, continues be a significant challenge. Protein-protein interactions mediated
by ubiquitin-like (Ubl) modifications are among the most important signalling
and regulatory mechanisms that control nearly every aspect of cellular func-
tions. A unique feature of these post-translational modifications is the forma-
tion of poly-Ubl chains; however, strategies to target these poly-Ubl chain
modified proteins are lacking. In this study, we show that gold nanparticles
(AuNPs) conjugated with small molecule inhibitors can selectively target
such poly-Ubl chains. Virtual ligand screening was carried out to identify small
molecule mimmetics of the Small Ubiquitin-like MOdifier (SUMO) interaction
motif in order to inhibit SUMO-mediated down-stream effects. Virtual ligand
screening was based on the NMR structure of SUMO in complex with a peptide
containing the SUMO-interaction motif. Interactions of the hit compounds with
SUMO were investigated by NMR methods. One of the hits was modified for
conjugation to an AuNP by adding a thiol tail. While the individual compounds
do not have high affinity for SUMO (having Kd of 2 mM), conjugation of ap-
proximately 100 compounds to one AuNP allows for multi-valent interactions
between AuNP and multiple SUMO proteins in a poly-SUMO chain; thus effi-
ciently inhibits poly-SUMO-chain-mediated protein-protein interactions. This
study demonstrates a viable approach to creating highly effective inhibitors
by using AuNPs as a platform for multivalent interactions. This is the first
application of AuNP for inhibiting Ubl modifications and provides a novel ap-
proach to specifically and effectively address such types of Ubl modifications
for future research and therapeutic applications.
3931-MiniSymp
New Approaches to Anti-Infective and Anti-Cancer Therapeutics
Targeting Metalloproteins
Eric Oldfield.
university of illinois at urbana, urbana, IL, USA.
I will give an account of recent progress in the development of novel anti-in-
fectives targeting isoprenoid biosynthesis. Topics to be covered include: carot-
enoid biosynthesis as a target in staph and malaria; novel inhibitors of bacterial
farnesyl and undecaprenyl diphosphate synthase; and the mechanism of action
of the Fe4S4 cluster-containing proteins, GcpE (IspG) and LytB (IspH). We
have investigated the mechanism of action and inhibition of Aquifex aeolicus
LytB using a combination of site-directed mutagenesis (KM, Vmax), EPR and
1H, 2H, 13C, 31P and 57Fe-ENDOR. The EPR and ENDOR results support
formation of an initial pi/sigma ‘‘metallacycle’’ complex similar to that ob-
served previously with allyl alcohol bound to a nitrogenase FeMo cofactor.
The complex is poised to interact with the E126 CO2H group, resulting in
loss of H2O and formation of eta1 and/or eta3-allyl complexes. The IPP and
DMAPP products are then formed in a second Hþ/e- reduction step. We also
report that alkyne diphosphates are inhibitors of IspH and likewise form pi
or pi/sigma metallacycle complexes, as evidenced by 1H, 2H, and 13C
ENDOR. I will also give an update on the mechanism of action of GcpE,
and the discovery of potent, mechanism-based, inhibitors of this enzyme.Platform BF: Cardiac Muscle II
3932-Plat
Proteomics of the Human Cardiac Intercalated Disc: A More Complex
Multi-Functional Structure than was Previously Thought
Cristobal G. dos Remedios1, Colleen Estigoy2, Darryl Cameron3,
Joshua W.K. Ho3, Benjamin Herbert4, Matthew Padula4, Russel Pickford5,
Michael Guilhaus5, Jacob Odeberg6, Fredrik Ponten7.
1University of Sydney, Sydney, Australia, 2Bosch Institute (F13), The
University of Sydney, Sydney, Australia, 3The University of Sydney, Sydney,
Australia, 4University of Technology Sydney, Sydney, Australia, 5University
of New South Wales, Kensington, Australia, 6Royal Institute of Technology,
Stockholm, Sweden, 7University of Uppsala, Uppsala, Sweden.
The intercalated disc (ICD) of cardiac muscle joins one cardiomyocyte to sev-
eral others. It transmits contractile force between these heart muscle cells, but it
also must allow action potentials, ions and even small molecules to cross the
junctions, it contains multiple receptors, and must permit the cardiomyocytes
to grow. The literature contains 142 proteins in mammalian hearts that were
identified using a wide range of techniques. Here we employ two technologies
that nearly double this number. We use Fourier transform mass spectrometry to
identify 84 proteins based on an analysis of their tryptic peptides using purified
(but not pure) ICDs from human left ventricles from four non-failing hearts,
only about half of which (43) were previously known. We then explore the
Human Proteome Atlas (HPA) database to identify 162 ICD proteins using
